Cargando…

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months

BACKGROUND: In Australia, seasonal inactivated influenza vaccine is typically offered in April. However, the onset, peak and end of a typical influenza season vary, and optimal timing for vaccination remains unclear. Here, we investigated vaccine‐induced antibody response kinetics over 6 months in d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordant, Francesca L., Price, Olivia H., Rudraraju, Rajeev, Slavin, Monica A., Marshall, Caroline, Worth, Leon J., Peck, Heidi, Barr, Ian G., Sullivan, Sheena G., Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835415/ https://www.ncbi.nlm.nih.gov/pubmed/36451293 http://dx.doi.org/10.1111/irv.13072

Ejemplares similares

Antibody titres decline 3-month post-vaccination with BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan
por: Wangmo, Karma, et al.
Publicado: (2019)

Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults
por: Erice, Alejo, et al.
Publicado: (2022)

Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine
por: Nomura, Yushi, et al.
Publicado: (2021)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
por: Agarkhedkar, Sharad, et al.
Publicado: (2019)

LHC Re-Opening Delayed at Least Two Months
Publicado: (2009)

Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China
por: Shi, Tianpei, et al.
Publicado: (2023)

Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
por: Messina, Nicole L, et al.
Publicado: (2022)

Vaccines for Pandemic Influenza
por: Luke, Catherine J., et al.
Publicado: (2006)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

H5N1 Viruses and Vaccines
por: Subbarao, Kanta, et al.
Publicado: (2007)

Respiratory Virus Vaccines
por: Broadbent, Andrew J., et al.
Publicado: (2015)

Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
por: Parthymou, Anastasia, et al.
Publicado: (2022)

Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months
por: Low, Ee Vien, et al.
Publicado: (2022)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2017)

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
por: Zou, Shi, et al.
Publicado: (2022)

Association of Maternal Inactivated COVID-19 Vaccination within 3 Months before Conception with Neonatal Outcomes
por: Chen, Zhihui, et al.
Publicado: (2023)

Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study
por: Ito, Kazuya, et al.
Publicado: (2018)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15–18 months
por: Sáez-Llorens, Xavier, et al.
Publicado: (2020)

Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination
por: Wang, Fuzhen, et al.
Publicado: (2022)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
por: Olotu, Ally, et al.
Publicado: (2011)

Safety, Immunogenicity and Duration of Immunity Elicited by an Inactivated Bovine Ephemeral Fever Vaccine
por: Aziz-Boaron, Orly, et al.
Publicado: (2013)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV
por: Wu, Songjie, et al.
Publicado: (2022)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
por: Wu, Songjie, et al.
Publicado: (2023)

T cell perturbations persist for at least 6 months following hospitalization for COVID-19
por: Govender, Melissa, et al.
Publicado: (2022)

The Longest Month: Analyzing COVID-19 Vaccination Opinions Dynamics From Tweets in the Month Following the First Vaccine Announcement
Publicado: (2021)

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
por: Fox, Annette, et al.
Publicado: (2022)

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021)

How to develop 8 vaccines in 12 months
por: Gross, Michael
Publicado: (2021)

COVID-19 Vaccine Hesitancy in the Month Following the Start of the Vaccination Process
por: Cotfas, Liviu-Adrian, et al.
Publicado: (2021)

Inactivated tick-borne encephalitis vaccine elicits several overlapping waves of T cell response
por: Sycheva, Anastasiia L., et al.
Publicado: (2022)

Persistence of vaccine-induced antibodies to A/H5N1 at 30 months and 36 months after vaccination in Vietnam
por: Chinh, Chien Vien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ng8kveurkv9bgcdt22en918e8